Prospective Study to Observe and Manage Progression of Pulmonary Nodules
Diagnosis and Management of Incidental Pulmonary Nodules: a Prospective Study
1 other identifier
observational
2
0 countries
N/A
Brief Summary
Based on the previous review and research, we would like to further observe the nodule changes in patients with pulmonary nodules. These changes include factors such as the reason for the further enlargement or deterioration of the nodule, time, lifestyle, the patient's region, and hereditary medical history. At the same time, we will further look at the corresponding characteristics of a population that does not change the size and nature of the nodule, including age, gender, and all the factors discussed above. On this basis, we can propose more scientific methods for the treatment and management of pulmonary nodules, and provide a more reliable clinical reference for the clinical treatment of pulmonary nodules.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2022
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 19, 2022
CompletedFirst Posted
Study publicly available on registry
August 22, 2022
CompletedStudy Start
First participant enrolled
August 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedAugust 22, 2022
August 1, 2022
11 months
August 19, 2022
August 19, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Changes in nodule size by CT scan in patients with pulmonary nodules during follow-up.
Changes in nodule size by CT scan in patients with pulmonary nodules during follow-up.
6 months
Eligibility Criteria
LNs patients aged 18 years and older who were previously treated in Guang'anmen hospital.
You may qualify if:
- LNs patients aged 18 years and older who were previously treated in Guang'anmen hospital.
You may not qualify if:
- (1) had the LNs removed; (2) LNs less than or equal to 3 mm in size; (3) had not undergone thorax CT; (4) had failed to complete treatment; (5) had incomplete medical records or was lost to follow-up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 19, 2022
First Posted
August 22, 2022
Study Start
August 30, 2022
Primary Completion
August 1, 2023
Study Completion
December 31, 2023
Last Updated
August 22, 2022
Record last verified: 2022-08